Aumento da suscetibilidade ao pentilenotetrazol após a sobrevivência de um quadro de malária cerebral em camundongos

Detalhes bibliográficos
Ano de defesa: 2017
Autor(a) principal: Grauncke, Ana Claudia Beck lattes
Orientador(a): Oliveira, Mauro Schneider lattes
Banca de defesa: Nogueira, Cristina Wayne lattes, Fleck, Juliana lattes
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Santa Maria
Centro de Ciências da Saúde
Programa de Pós-Graduação: Programa de Pós-Graduação em Farmacologia
Departamento: Farmacologia
País: Brasil
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://repositorio.ufsm.br/handle/1/13729
Resumo: Malaria is considered a neglected disease and public health problem, affecting more than 200 million people worldwide. Plasmodium falciparum, one of the four human parasitic species, is responsible for the development of severe malaria, which can lead to coma or patient death. One of major manifestation of this infection is cerebral malaria (CM), a neurological complication and a potential cause of epilepsy in malaria-endemic regions. In the present study we used the Plasmodium berghei ANKA (PbA) model of experimental cerebral malaria (CM) in C57BL/6 male mice (CEUA 020, 2014), where was verified the susceptibility of pentylenetetrazol (PTZ) - induced seizures 45 days after infection, with rescue from CM and parasite clearance, through electroencephalographic analysis. Our results showed that the administration of a subconvulsant dose of pentylenetetrazol (30 mg/Kg) is capable to alter the latency to myoclonic and tonic-clonic seizures in infected mice, as well increase the duration of tonic-clonic seizures. In addition, quantitative analysis of electroencephalogram revealed a decrease in relative power at beta frequency band in PbA-infected animals after PTZ injection. EEG recordings demonstrated an increased susceptibility of mice infected with PbA to myoclonic, tonic-clonic seizures. These results demonstrated that experimental cerebral malaria caused central nervous system (CNS) changes that facilitate the occurrence and increase the duration of seizures. However, additional studies are necessary to evaluate the molecular mechanisms underlying our findings as well as its clinical implications.
id UFSM_779cbcea9e56f02091fc7aeb58989ff1
oai_identifier_str oai:repositorio.ufsm.br:1/13729
network_acronym_str UFSM
network_name_str Biblioteca Digital de Teses e Dissertações do UFSM
repository_id_str
spelling 2018-07-10T15:40:21Z2018-07-10T15:40:21Z2017-07-10http://repositorio.ufsm.br/handle/1/13729Malaria is considered a neglected disease and public health problem, affecting more than 200 million people worldwide. Plasmodium falciparum, one of the four human parasitic species, is responsible for the development of severe malaria, which can lead to coma or patient death. One of major manifestation of this infection is cerebral malaria (CM), a neurological complication and a potential cause of epilepsy in malaria-endemic regions. In the present study we used the Plasmodium berghei ANKA (PbA) model of experimental cerebral malaria (CM) in C57BL/6 male mice (CEUA 020, 2014), where was verified the susceptibility of pentylenetetrazol (PTZ) - induced seizures 45 days after infection, with rescue from CM and parasite clearance, through electroencephalographic analysis. Our results showed that the administration of a subconvulsant dose of pentylenetetrazol (30 mg/Kg) is capable to alter the latency to myoclonic and tonic-clonic seizures in infected mice, as well increase the duration of tonic-clonic seizures. In addition, quantitative analysis of electroencephalogram revealed a decrease in relative power at beta frequency band in PbA-infected animals after PTZ injection. EEG recordings demonstrated an increased susceptibility of mice infected with PbA to myoclonic, tonic-clonic seizures. These results demonstrated that experimental cerebral malaria caused central nervous system (CNS) changes that facilitate the occurrence and increase the duration of seizures. However, additional studies are necessary to evaluate the molecular mechanisms underlying our findings as well as its clinical implications.A malária é considerada uma doença negligenciada e um problema de saúde pública, afetando mais de 200 milhões de pessoas em todo o mundo. O Plasmodium falciparum, uma das quatro espécies parasíticas humanas, é responsável pelo desenvolvimento do quadro de malária grave, o qual pode levar o paciente ao coma, ou até a morte. Uma das principais manifestações desta infecção é a malária cerebral (MC), uma complicação neurológica e também, uma potencial causa de epilepsia em regiões endêmicas. No presente estudo nós utilizamos o modelo de malária cerebral experimental induzida pela inoculação do Plasmodium berghei ANKA (PbA) em camundongos C57BL/6 machos (CEUA 020/2014), no qual verificou-se a suscetibilidade para crises convulsivas induzidas por pentilenotetrazol (PTZ) 45 dias pós-infecção, após a remissão da MC e a eliminação total do parasita, através de análises eletroencefalográficas. Nossos resultados mostraram que a administração de uma dose subconvulsivante de PTZ (30 mg/Kg) é capaz de alterar a latência para crises mioclônicas e tônico-clônicas nos animais infectados, bem como aumentar a duração das crises convulsivas tônico-clônicas. Além disso, foi visto na análise quantitativa do eletroencefalograma que houve uma diminuição no poder relativo na banda de frequência beta nos animais infectados com PbA após a injeção de PTZ. Os registros eletroencefalográficos demonstraram um aumento na suscetibilidade dos camundongos infectados com PbA para crises mioclônicas e tônico-clônicas. Esses resultados demonstram que a malária cerebral experimental causa mudanças no sistema nervoso central (SNC) que facilitam a ocorrência e aumentam a duração das crises. Entretanto, mais estudos são necessários para avaliar o mecanismo molecular envolvendo nossos resultados, bem como sua implicação clínica.Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPqporUniversidade Federal de Santa MariaCentro de Ciências da SaúdePrograma de Pós-Graduação em FarmacologiaUFSMBrasilFarmacologiaAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessEletroencefalografiaEpilepsiaMaláriaPentilenotetrazolPlasmodium berghei ANKAElectroencephalographyEpilepsyMalariaPentylenetetrazolPlasmodium berghei ANKACNPQ::CIENCIAS DA SAUDE::FARMACIAAumento da suscetibilidade ao pentilenotetrazol após a sobrevivência de um quadro de malária cerebral em camundongosIncreased susceptibility to pentylenetetrazol following survival of cerebral malaria in miceinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisOliveira, Mauro Schneiderhttp://lattes.cnpq.br/7132934163734175http://lattes.cnpq.br/2877042401245169Nogueira, Cristina Waynehttp://lattes.cnpq.br/2877042401245169Fleck, Julianahttp://lattes.cnpq.br/1497762896019410http://lattes.cnpq.br/5559444682483502Grauncke, Ana Claudia Beck40030000000560085c7bcbb-76c9-41fa-9c05-5216c865f0b477752746-a2a2-4502-a7dc-b08ec5e601b51e373fcc-89bd-4103-adba-676f6dcec7871061f325-eb1b-462a-889e-04c8f0051208reponame:Biblioteca Digital de Teses e Dissertações do UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMORIGINALDIS_PPGFARMACOLOGIA_2017_GRAUNCKE_ANA.pdfDIS_PPGFARMACOLOGIA_2017_GRAUNCKE_ANA.pdfDissertação de Mestradoapplication/pdf3717630http://repositorio.ufsm.br/bitstream/1/13729/1/DIS_PPGFARMACOLOGIA_2017_GRAUNCKE_ANA.pdff081fcfaf154ccaa28fa18bf4cda22b5MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8804http://repositorio.ufsm.br/bitstream/1/13729/2/license_rdfc1efe8e24d7281448e873be30ea326ffMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81956http://repositorio.ufsm.br/bitstream/1/13729/3/license.txt2f0571ecee68693bd5cd3f17c1e075dfMD53TEXTDIS_PPGFARMACOLOGIA_2017_GRAUNCKE_ANA.pdf.txtDIS_PPGFARMACOLOGIA_2017_GRAUNCKE_ANA.pdf.txtExtracted texttext/plain63467http://repositorio.ufsm.br/bitstream/1/13729/4/DIS_PPGFARMACOLOGIA_2017_GRAUNCKE_ANA.pdf.txt52cd673f654a660bdfb0693d0cf38a11MD54THUMBNAILDIS_PPGFARMACOLOGIA_2017_GRAUNCKE_ANA.pdf.jpgDIS_PPGFARMACOLOGIA_2017_GRAUNCKE_ANA.pdf.jpgIM Thumbnailimage/jpeg4519http://repositorio.ufsm.br/bitstream/1/13729/5/DIS_PPGFARMACOLOGIA_2017_GRAUNCKE_ANA.pdf.jpg1df7d91ffdb77b8ac5f77e933019fd4bMD551/137292018-07-10 12:40:22.03oai:repositorio.ufsm.br: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 Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2018-07-10T15:40:22Biblioteca Digital de Teses e Dissertações do UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.por.fl_str_mv Aumento da suscetibilidade ao pentilenotetrazol após a sobrevivência de um quadro de malária cerebral em camundongos
dc.title.alternative.eng.fl_str_mv Increased susceptibility to pentylenetetrazol following survival of cerebral malaria in mice
title Aumento da suscetibilidade ao pentilenotetrazol após a sobrevivência de um quadro de malária cerebral em camundongos
spellingShingle Aumento da suscetibilidade ao pentilenotetrazol após a sobrevivência de um quadro de malária cerebral em camundongos
Grauncke, Ana Claudia Beck
Eletroencefalografia
Epilepsia
Malária
Pentilenotetrazol
Plasmodium berghei ANKA
Electroencephalography
Epilepsy
Malaria
Pentylenetetrazol
Plasmodium berghei ANKA
CNPQ::CIENCIAS DA SAUDE::FARMACIA
title_short Aumento da suscetibilidade ao pentilenotetrazol após a sobrevivência de um quadro de malária cerebral em camundongos
title_full Aumento da suscetibilidade ao pentilenotetrazol após a sobrevivência de um quadro de malária cerebral em camundongos
title_fullStr Aumento da suscetibilidade ao pentilenotetrazol após a sobrevivência de um quadro de malária cerebral em camundongos
title_full_unstemmed Aumento da suscetibilidade ao pentilenotetrazol após a sobrevivência de um quadro de malária cerebral em camundongos
title_sort Aumento da suscetibilidade ao pentilenotetrazol após a sobrevivência de um quadro de malária cerebral em camundongos
author Grauncke, Ana Claudia Beck
author_facet Grauncke, Ana Claudia Beck
author_role author
dc.contributor.advisor1.fl_str_mv Oliveira, Mauro Schneider
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/7132934163734175
dc.contributor.advisor2Lattes.fl_str_mv http://lattes.cnpq.br/2877042401245169
dc.contributor.referee1.fl_str_mv Nogueira, Cristina Wayne
dc.contributor.referee1Lattes.fl_str_mv http://lattes.cnpq.br/2877042401245169
dc.contributor.referee2.fl_str_mv Fleck, Juliana
dc.contributor.referee2Lattes.fl_str_mv http://lattes.cnpq.br/1497762896019410
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/5559444682483502
dc.contributor.author.fl_str_mv Grauncke, Ana Claudia Beck
contributor_str_mv Oliveira, Mauro Schneider
Nogueira, Cristina Wayne
Fleck, Juliana
dc.subject.por.fl_str_mv Eletroencefalografia
Epilepsia
Malária
Pentilenotetrazol
Plasmodium berghei ANKA
topic Eletroencefalografia
Epilepsia
Malária
Pentilenotetrazol
Plasmodium berghei ANKA
Electroencephalography
Epilepsy
Malaria
Pentylenetetrazol
Plasmodium berghei ANKA
CNPQ::CIENCIAS DA SAUDE::FARMACIA
dc.subject.eng.fl_str_mv Electroencephalography
Epilepsy
Malaria
Pentylenetetrazol
Plasmodium berghei ANKA
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS DA SAUDE::FARMACIA
description Malaria is considered a neglected disease and public health problem, affecting more than 200 million people worldwide. Plasmodium falciparum, one of the four human parasitic species, is responsible for the development of severe malaria, which can lead to coma or patient death. One of major manifestation of this infection is cerebral malaria (CM), a neurological complication and a potential cause of epilepsy in malaria-endemic regions. In the present study we used the Plasmodium berghei ANKA (PbA) model of experimental cerebral malaria (CM) in C57BL/6 male mice (CEUA 020, 2014), where was verified the susceptibility of pentylenetetrazol (PTZ) - induced seizures 45 days after infection, with rescue from CM and parasite clearance, through electroencephalographic analysis. Our results showed that the administration of a subconvulsant dose of pentylenetetrazol (30 mg/Kg) is capable to alter the latency to myoclonic and tonic-clonic seizures in infected mice, as well increase the duration of tonic-clonic seizures. In addition, quantitative analysis of electroencephalogram revealed a decrease in relative power at beta frequency band in PbA-infected animals after PTZ injection. EEG recordings demonstrated an increased susceptibility of mice infected with PbA to myoclonic, tonic-clonic seizures. These results demonstrated that experimental cerebral malaria caused central nervous system (CNS) changes that facilitate the occurrence and increase the duration of seizures. However, additional studies are necessary to evaluate the molecular mechanisms underlying our findings as well as its clinical implications.
publishDate 2017
dc.date.issued.fl_str_mv 2017-07-10
dc.date.accessioned.fl_str_mv 2018-07-10T15:40:21Z
dc.date.available.fl_str_mv 2018-07-10T15:40:21Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/13729
url http://repositorio.ufsm.br/handle/1/13729
dc.language.iso.fl_str_mv por
language por
dc.relation.cnpq.fl_str_mv 400300000005
dc.relation.confidence.fl_str_mv 600
dc.relation.authority.fl_str_mv 85c7bcbb-76c9-41fa-9c05-5216c865f0b4
77752746-a2a2-4502-a7dc-b08ec5e601b5
1e373fcc-89bd-4103-adba-676f6dcec787
1061f325-eb1b-462a-889e-04c8f0051208
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Farmacologia
dc.publisher.initials.fl_str_mv UFSM
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Farmacologia
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações do UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Biblioteca Digital de Teses e Dissertações do UFSM
collection Biblioteca Digital de Teses e Dissertações do UFSM
bitstream.url.fl_str_mv http://repositorio.ufsm.br/bitstream/1/13729/1/DIS_PPGFARMACOLOGIA_2017_GRAUNCKE_ANA.pdf
http://repositorio.ufsm.br/bitstream/1/13729/2/license_rdf
http://repositorio.ufsm.br/bitstream/1/13729/3/license.txt
http://repositorio.ufsm.br/bitstream/1/13729/4/DIS_PPGFARMACOLOGIA_2017_GRAUNCKE_ANA.pdf.txt
http://repositorio.ufsm.br/bitstream/1/13729/5/DIS_PPGFARMACOLOGIA_2017_GRAUNCKE_ANA.pdf.jpg
bitstream.checksum.fl_str_mv f081fcfaf154ccaa28fa18bf4cda22b5
c1efe8e24d7281448e873be30ea326ff
2f0571ecee68693bd5cd3f17c1e075df
52cd673f654a660bdfb0693d0cf38a11
1df7d91ffdb77b8ac5f77e933019fd4b
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações do UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1793239987182895104